Preoperative Optimization for Elective Surgery in Crohn's Disease: A Narrative Review.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1576, doi. 10.3390/jcm14051576
- By:
- Publication type:
- Article
Works matching AU Hazel, Karl
Results: 6
1
2
Nutraceutical targeting of the bile acid receptor, farnesoid X receptor, for intestinal disease.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4543
- By:
- Publication type:
- Article
3
Strictureplasty versus bowel resection for the surgical management of fibrostenotic Crohn's disease: a systematic review and meta-analysis.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 4, p. 705, doi. 10.1007/s00384-020-03507-z
- By:
- Publication type:
- Article
4
Emerging treatments for inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622319899297
- By:
- Publication type:
- Article
5
Emerging treatments for inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, p. 1, doi. 10.1177/2040622319899297
- By:
- Publication type:
- Article
6
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease.
- Published in:
- Scandinavian Journal of Gastroenterology, 2020, v. 55, n. 7, p. 786, doi. 10.1080/00365521.2020.1779340
- By:
- Publication type:
- Article